Anti-IL-5 Therapy in Bullous Pemphigoid (BP)
Clinical trial NCT01705795 · COMPLETED
Trial details
- NCT number
- NCT01705795
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-13
- Primary completion
- 2017-01-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.